罗沙沙斯塔特对腹腔透析患者的铁代谢的影响:现实世界24周研究
Xuejie Zhang1,2, Ruoyu Jia3, Zhifang Zheng1
1Department of Nephrology, Affiliated Hospital of Xuzhou Medical University, 99 West Huai-Hai Road, Xuzhou, 221002, Jiangsu, China.
European journal of medical research
|November 8, 2023
概括
与ESA相比,Roxadustat在腹腔透析患者中显著改善了铁代谢生物标志物. 这种口服的HIF-PHI提供了一个优越的治疗选择,用于管理该人口的铁缺乏症.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學專業.
- 血液学 血液学 血液学
- 药理学 药理学是指药理学的学科.
背景情况:
- 罗沙杜沙特是一种口服的缺氧诱导因子-基酶抑制剂 (HIF-PHI),通过减少肝素和调动铁储量来调节铁代谢.
- 与红色素形成刺激剂 (ESAs) 相比,在腹腔透析 (PD) 患者的铁代谢中使用roxadustat的疗效数据需要进一步调查.
研究的目的:
- 为了比较roxadustat与ESAs在调节PD患者的铁代谢中的疗效.
- 评估铁生物标志物水平的变化和铁缺乏症的患病率.
主要方法:
- 一项前性队列研究,涉及PD患者的血红蛋白水平为60-100g/L.
- 随机选择的2:1比分为roxadustat (106例) 和ESA (53例) 组.
- 主要终点:铁生物标志物的变化和绝对和功能性铁缺乏症患者的比例.
主要成果:
- 与ESA相比,Roxadustat显著降低了肝素水平 (差异: -20.09 ng/mL) 和减弱的血清可溶性转激素受体 (sTFR) 的增加 (差异: -7.87 nmol/L).
- 功能性铁缺乏症降低的患病率:11.43%在roxadustat组,而在ESA组为33.33%.
- 两组之间没有观察到任何显著的安全差异.
结论:
- 与ESA相比,Roxadustat显示出铁生物标志物水平的显著改善,不包括血清费里丁 (sFt) 和转激素和度 (TSAT).
- 罗沙杜沙特似乎优于ESAs来控制PD患者的铁代谢.
- 这项研究于2022年3月4日注册 (ChiCTR2200057231).
相关概念视频
Chronic Kidney Disease III: Interprofessional Care
13
Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
13
Peritoneal Dialysis II: Peritoneal Dialysis Systems and Complications
26
Peritoneal dialysis (PD) is a medical process that removes waste products and excess fluid from the body using the peritoneal membrane as a natural filter.Peritoneal Dialysis MethodsSeveral methods can be used for peritoneal dialysis, including Acute Intermittent Peritoneal Dialysis, Continuous Ambulatory Peritoneal Dialysis, and Automated Peritoneal Dialysis, also known as Continuous Cyclic Peritoneal Dialysis.Acute Intermittent Peritoneal Dialysis (AIPD) is used for patients with uremic...
26
Peritoneal Dialysis I: Introduction and Procedure
37
Peritoneal dialysis (PD) is a procedure that facilitates the exchange of solutes, waste products, electrolytes, and excess fluid between the blood in the peritoneal capillaries and a dialysis solution introduced into the peritoneal cavity.Principles of Peritoneal Dialysis (PD)Diffusion: Waste products such as urea and electrolytes move from high concentrations in the blood to low concentrations in the dialysate across the peritoneal membrane. This mechanism is driven by the concentration...
37
Renal Failure: Dose Adjustments
96
In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
96
Dialysis
330
Renal failure occurs when the kidneys lose their ability to filter waste products from the blood effectively. It can be classified into two types: acute renal failure (ARF) and chronic renal failure (CRF).
Acute kidney injury develops suddenly and can be caused by pre-renal causes (e.g., hypovolemia, shock), intrinsic renal causes (e.g., acute tubular necrosis), or post-renal causes (e.g., urinary obstruction). In contrast, chronic renal failure progresses gradually over time and is often...
Acute kidney injury develops suddenly and can be caused by pre-renal causes (e.g., hypovolemia, shock), intrinsic renal causes (e.g., acute tubular necrosis), or post-renal causes (e.g., urinary obstruction). In contrast, chronic renal failure progresses gradually over time and is often...
330
Hemodialysis III: Nursing Management
25
The nursing management of a patient undergoing hemodialysis includes several critical steps, starting with a thorough assessment before the procedure.Before the Hemodialysis ProcedureFirst, record the patient's vital signs—blood pressure, heart rate, respiratory rate, and temperature—to establish a baseline. This baseline is essential for detecting conditions such as hypotension that could impact the patient's response to dialysis. Document the patient's pre-dialysis weight, as this...
25


